HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tao Peng Selected Research

Interferon Type I

1/2022The Molecular Mechanism of Herpes Simplex Virus 1 UL31 in Antagonizing the Activity of IFN-β.
1/2020Epstein-Barr Virus Early Protein BFRF1 Suppresses IFN-β Activity by Inhibiting the Activation of IRF3.
5/2008Attenuation of the type I interferon response in cells infected with human rhinovirus.
5/2006Human rhinovirus attenuates the type I interferon response by disrupting activation of interferon regulatory factor 3.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tao Peng Research Topics

Disease

133Neoplasms (Cancer)
03/2024 - 07/2005
89Hepatocellular Carcinoma (Hepatoma)
03/2024 - 10/2005
50Infections
02/2024 - 06/2002
20Inflammation (Inflammations)
04/2024 - 06/2005
17Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 06/2007
16Neoplasm Metastasis (Metastasis)
01/2024 - 01/2009
16Adenocarcinoma
01/2023 - 01/2017
10Liver Neoplasms (Liver Cancer)
09/2023 - 01/2014
10Nasopharyngeal Carcinoma
03/2023 - 10/2008
9Colorectal Neoplasms (Colorectal Cancer)
03/2024 - 01/2014
9Carcinogenesis
10/2023 - 12/2004
9Ischemic Stroke
03/2023 - 10/2013
9Stroke (Strokes)
01/2023 - 10/2013
9Virus Diseases (Viral Diseases)
01/2022 - 08/2010
8Carcinoma (Carcinomatosis)
08/2023 - 11/2007
8Glioma (Gliomas)
01/2022 - 01/2015
7Hemorrhage
10/2023 - 01/2020
7Prostatic Neoplasms (Prostate Cancer)
01/2023 - 11/2007
7COVID-19
01/2023 - 06/2020
7Liver Diseases (Liver Disease)
01/2020 - 01/2009
6Hepatitis B
01/2023 - 02/2007
6Asthma (Bronchial Asthma)
01/2022 - 06/2005
6Stomach Neoplasms (Stomach Cancer)
01/2019 - 06/2007
6Proteinuria
08/2018 - 01/2009
6Body Weight (Weight, Body)
12/2017 - 07/2007
5Circulating Neoplastic Cells
03/2024 - 01/2018
5Breast Neoplasms (Breast Cancer)
01/2024 - 04/2010
5Disease Progression
01/2023 - 06/2018
5Chronic Obstructive Pulmonary Disease (COPD)
07/2022 - 09/2019
5Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2022 - 03/2015
5Pancreatitis
11/2017 - 09/2015
4Wounds and Injuries (Trauma)
05/2024 - 01/2019
4Lung Neoplasms (Lung Cancer)
03/2024 - 08/2010
4Reperfusion Injury
12/2023 - 10/2013
4Brain Ischemia (Cerebral Ischemia)
12/2023 - 10/2013
4Insulin Resistance
12/2023 - 01/2013
4Necrosis
01/2023 - 02/2018
4Ischemia
01/2022 - 10/2013
4Acute Kidney Injury (Acute Renal Failure)
01/2022 - 01/2016
4Hypoxia (Hypoxemia)
01/2021 - 01/2016
4Deafness (Deaf Mutism)
04/2019 - 01/2015
4Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
01/2018 - 01/2013
4Chronic Hepatitis B
01/2018 - 12/2011

Drug/Important Bio-Agent (IBA)

61Proteins (Proteins, Gene)FDA Link
02/2024 - 08/2002
53Biomarkers (Surrogate Marker)IBA
03/2024 - 02/2007
31Messenger RNA (mRNA)IBA
01/2024 - 04/2005
18Antiviral Agents (Antivirals)IBA
01/2023 - 08/2009
17Long Noncoding RNAIBA
01/2024 - 10/2016
17AntigensIBA
08/2023 - 06/2002
16VaccinesIBA
01/2023 - 07/2005
15DNA (Deoxyribonucleic Acid)IBA
01/2022 - 12/2005
14RNA (Ribonucleic Acid)IBA
12/2023 - 02/2008
14MicroRNAs (MicroRNA)IBA
01/2021 - 01/2009
8Liposomes (Liposome)IBA
03/2023 - 10/2013
8EnzymesIBA
01/2023 - 11/2006
8Glucose (Dextrose)FDA LinkGeneric
01/2023 - 08/2002
8CytokinesIBA
01/2023 - 12/2011
8AntibodiesIBA
02/2022 - 03/2011
7GemcitabineFDA Link
12/2023 - 01/2017
7Sorafenib (BAY 43-9006)FDA Link
08/2023 - 01/2019
7Indicators and Reagents (Reagents)IBA
10/2022 - 01/2009
7CreatinineIBA
06/2018 - 01/2013
6Circular RNAIBA
01/2024 - 01/2018
6LipidsIBA
12/2023 - 01/2013
6InterferonsIBA
12/2023 - 10/2017
6XenonIBA
01/2023 - 10/2013
6Therapeutic UsesIBA
01/2022 - 11/2008
6Peroxynitrous Acid (Peroxynitrite)IBA
01/2018 - 01/2010
5Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2023 - 01/2014
5CarbohydratesIBA
09/2022 - 07/2005
5Aflatoxin B1 (Aflatoxin B)IBA
12/2020 - 11/2007
5Neuroprotective AgentsIBA
12/2018 - 10/2013
4Sirtuin 3IBA
10/2023 - 07/2020
4Interleukin-6 (Interleukin 6)IBA
02/2023 - 01/2018
4Interferon Type IIBA
01/2022 - 05/2006
4Tumor Biomarkers (Tumor Markers)IBA
01/2021 - 06/2007
4AutoantibodiesIBA
01/2021 - 05/2019
4Phosphotransferases (Kinase)IBA
01/2020 - 01/2013
4Protein Isoforms (Isoforms)IBA
05/2019 - 08/2014
4Transcription Factors (Transcription Factor)IBA
01/2019 - 11/2012
4Dinoprostone (PGE2)FDA Link
02/2018 - 11/2007
4CalciumIBA
11/2017 - 09/2004
4Alanine Transaminase (SGPT)IBA
01/2013 - 02/2007
4PhosphoproteinsIBA
05/2012 - 08/2010
3Chemokine ReceptorsIBA
03/2024 - 10/2017
3VimentinIBA
03/2024 - 03/2022
3NLR ProteinsIBA
03/2024 - 01/2021
3InflammasomesIBA
03/2024 - 06/2019

Therapy/Procedure

39Therapeutics
03/2024 - 06/2007
18Hepatectomy
10/2023 - 07/2016
16Drug Therapy (Chemotherapy)
10/2023 - 12/2005
10Pancreaticoduodenectomy
08/2023 - 01/2017
8Radiotherapy
02/2022 - 08/2013
5Stents
04/2024 - 01/2020
5Ligation
09/2023 - 06/2018
5Blood Transfusion (Blood Transfusions)
08/2023 - 12/2011
5Lasers (Laser)
10/2019 - 11/2007
4Aftercare (After-Treatment)
01/2023 - 06/2018
4Neoadjuvant Therapy
01/2023 - 09/2018
4Catheters
01/2021 - 02/2016